Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 10(1): 20645, 2020 11 26.
Article in English | MEDLINE | ID: mdl-33244152

ABSTRACT

Electroporation in combination with chemotherapy is an established treatment used on solid malignancies that results in enhanced chemotherapeutic uptake. Recent advances have begun to transition to the use of non-toxic compounds, such as calcium, in lieu of chemotherapy, which can also induce tumour cell death. While the effect of treatment on tumour cell death has been well characterized and has been shown to induce an immunogenic form of cell death, the effect of treatment on intratumoural immune cells has not been investigated. Here we present data showing the effect of calcium electroporation on immune cells, using melanoma-conditioned bone marrow-derived macrophages. Similar to tumour cells, macrophage cell membranes are susceptible to poration following treatment and subsequently reseal. Macrophages are less susceptible to calcium electroporation induced cell death in comparison to B16F10 melanoma cells. However treatment with electroporation with or without bleomycin or calcium was shown to affect macrophage phenotype and function. Coculture of calcium electroporated macrophages revealed that both the capacity of macrophages to stimulate and direct T cell responses are affected following exposure to treatment. We conclude that calcium electroporation has the potential to boost the immunogenic capacity of exposed tumour associated macrophages, and further research is warranted to determine if calcium electroporation can be optimised to generate systemic anti-cancer immune responses.


Subject(s)
Calcium/pharmacology , Cell Survival/drug effects , Macrophages/drug effects , Melanoma, Experimental/diet therapy , Animals , Bleomycin/pharmacology , Bone Marrow/drug effects , Cell Death/drug effects , Cell Line, Tumor , Cell Membrane/drug effects , Electroporation/methods , Female , Immunity/drug effects , Mice , Mice, Inbred C57BL , Phenotype , T-Lymphocytes/drug effects
2.
Br J Cancer ; 123(10): 1553-1561, 2020 11.
Article in English | MEDLINE | ID: mdl-32843682

ABSTRACT

BACKGROUND: The density and phenotype of tumour-associated macrophages have been linked with prognosis in a range of solid tumours. While there is strong preclinical evidence that tumour-associated macrophages promote aspects of tumour progression, it can be challenging to infer clinical activity from surface markers and ex vivo behaviour. We investigated the association of macrophage infiltration with prognosis and functional changes in the tumour microenvironment in primary human melanoma. METHODS: Fifty-seven formalin-fixed, paraffin-embedded primary melanomas were analysed by immunohistochemical analysis of CD68, CD163, inducible nitric oxide synthase (iNOS) and arginase expression. RNA sequencing was performed on serial sections of 20 of the stained tumours to determine the influence of macrophage infiltration on gene expression. RESULTS: CD68+ cells are a functionally active subset of macrophages that are associated with increased iNOS and arginase staining and altered gene expression. In comparison, while there is a greater accumulation of CD163+ macrophages in larger tumours, these cells are comparatively inactive, with no association with the level of iNOS or arginase staining, and no effect on gene expression within the tumour. The infiltration of either subset of macrophages did not correlate to overall survival. CONCLUSIONS: Thus, melanomas contain distinct macrophage populations with diverse phenotypes, but with no observable prognostic role.


Subject(s)
Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/metabolism , Genes, Neoplasm , Macrophages/metabolism , Melanoma/diagnosis , Receptors, Cell Surface/metabolism , Skin Neoplasms/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Cohort Studies , Disease Progression , Female , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Genes, Neoplasm/genetics , Humans , Macrophages/enzymology , Macrophages/pathology , Male , Melanoma/genetics , Melanoma/mortality , Melanoma/pathology , Middle Aged , Prognosis , Skin Neoplasms/genetics , Skin Neoplasms/mortality , Skin Neoplasms/pathology , Survival Analysis , Tumor Microenvironment/genetics , Young Adult
3.
Cancer Immunol Immunother ; 68(9): 1455-1465, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31444606

ABSTRACT

Macrophages have been shown to infiltrate a wide range of malignancies and are often considered to promote tumour survival, growth and spread. However, the source and behaviour of discrete tumour-associated macrophage populations are still poorly understood. Here we show a novel method for the rational development of bone marrow-derived monocytes appropriate for the study of processes which involve the contribution of circulating inflammatory monocytes. We have shown that in response to tumour-conditioned medium, these cells upregulate CD206 and CD115, markers traditionally associated with M2-type macrophages. Treated cells show reduced capacity for cytokine secretion but significantly impact CD4+ and CD8+ T-cell proliferation and polarization. Coculture with conditioned bone marrow-derived monocytes significantly reduced CD4+ T-cell proliferation but increased CD8+ T-cell proliferation and granzyme B expression with significant induction of IFNγ secretion by both CD4+ and CD8+ T cells, indicating that these cells may have a role in promoting anti-cancer immunity.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Macrophages/immunology , Melanoma/immunology , Monocytes/immunology , Skin Neoplasms/immunology , Animals , Bone Marrow Cells/cytology , Cell Differentiation , Coculture Techniques , Culture Media, Conditioned/metabolism , Cytokines/metabolism , Cytotoxicity, Immunologic , Lectins, C-Type/metabolism , Lymphocyte Activation , Mannose Receptor , Mannose-Binding Lectins/metabolism , Melanoma, Experimental , Mice , Mice, Inbred C57BL , Neoplasms, Experimental , Receptor, Macrophage Colony-Stimulating Factor/metabolism , Receptors, Cell Surface/metabolism , Th2 Cells/immunology
4.
Cancer Lett ; 442: 475-482, 2019 02 01.
Article in English | MEDLINE | ID: mdl-30472183

ABSTRACT

Electrochemotherapy is an emerging treatment modality for cancer patients which can effectively reduce tumour burden and induce immunogenic cell death. Electrochemotherapy is most commonly used with bleomycin as the drug of choice, here we examine the efficacy of electrochemotherapy with cisplatin. Electrochemotherapy with cisplatin was found to effectively reduce tumour growth in a range of murine models and induce significant intratumoural recruitment of myeloid and humoral immune cells. Following the observations of immune system mobilisation, we have shown an ability of electrochemotherapy to reduce metastatic potential as determined by tumour burden in the lung, and to exert an abscopal effect by reducing growth at distal untreated secondary tumours.


Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Lewis Lung/drug therapy , Cisplatin/pharmacology , Electrochemotherapy , Lung Neoplasms/drug therapy , Melanoma, Experimental/drug therapy , Skin Neoplasms/drug therapy , Animals , Carcinoma, Lewis Lung/immunology , Carcinoma, Lewis Lung/pathology , Cell Line, Tumor , Cell Proliferation/drug effects , Immunity, Humoral/drug effects , Lung Neoplasms/immunology , Lung Neoplasms/pathology , Melanoma, Experimental/immunology , Melanoma, Experimental/pathology , Myeloid Cells/drug effects , Myeloid Cells/immunology , Skin Neoplasms/immunology , Skin Neoplasms/pathology , Time Factors , Tumor Burden/drug effects
5.
Cancer Immunol Immunother ; 66(12): 1509-1527, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28948324

ABSTRACT

The focus of immunotherapeutics has been placed firmly on anti-tumour T cell responses. Significant progress has been made in the treatment of both local and systemic malignancies, but low response rates and rising toxicities are limiting this approach. Advancements in the understanding of tumour immunology are opening up a new range of therapeutic targets, including immunosuppressive factors in the tumour microenvironment. Macrophages are a heterogeneous group of cells that have roles in innate and adaptive immunity and tissue repair, but become co-opted by tumours to support tumour growth, survival, metastasis and immunosuppression. Macrophages also support tumour resistance to conventional therapy. In preclinical models, interference with macrophage migration, macrophage depletion and macrophage re-education have all been shown to reduce tumour growth and support anti-tumour immune responses. Here we discuss the role of macrophages in prognosis and sensitivity to therapy, while examining the significant progress which has been made in modulating the behaviour of these cells in cancer patients.


Subject(s)
Macrophages/immunology , Neoplasms/immunology , Tumor Microenvironment/immunology , Humans , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL
...